Skip to main content

Copernicus Capital Management, LLC

SEC CIK
0001694620
Latest filing
Nov 15, 2021

Holdings in Q3 2021

Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.

Institution overview
Positions
13
+2 vs. Q2 2021
Portfolio value
$8.26M
+$1.92M (+30.3%) vs. Q2 2021
Filed
Nov 15, 2021
SEC
Holdings of Copernicus Capital Management, LLC in Q3 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
PFEPfizer IncStock30,000$1.29M15.6%+30,000NewHistory
TMOThermo Fisher Scientific Inc.Stock2,000$1.14M13.8%+2,000NewHistory
TDOCTeladoc Health, Inc.COM7,000$888.0K10.7%+7,000NewHistory
BMRNBiomarin Pharmaceutical IncCOM11,000$850.0K10.3%+11,000NewHistory
JNJJohnson & JohnsonStock5,000$808.0K9.8%+5,000NewHistory
FATEFate Therapeutics IncCOM12,000$711.0K8.6%+2,000+20.0%AddedHistory
HZNPHorizon Therapeutics Public Ltd CoSHS6,000$657.0K8.0%+1,000+20.0%AddedHistory
RCUSArcus Biosciences, Inc.COM17,000$593.0K7.2%−3,000−15.0%ReducedHistory
ALLOAllogene Therapeutics, Inc.COM15,000$386.0K4.7%+15,000NewHistory
MDTMedtronic plcStock3,000$376.0K4.6%+3,000NewHistory
PRQRProQR Therapeutics N.V.SHS EURO40,000$335.0K4.1%+40,000NewHistory
IMTXImmatics N.V.SHS10,000$130.0K1.6%+10,000NewHistory
FOLDAmicus Therapeutics, Inc.COM10,000$96.0K1.2%+10,000NewHistory

Sold out since Q2 2021 (8)

Positions held at the end of Q2 2021 that are gone from this filing.

Positions of Copernicus Capital Management, LLC sold out since Q2 2021
SecurityClassShares in Q2 2021Value in Q2 2021% of portfolio in Q2 2021History
VRTXVertex Pharmaceuticals IncStock9,000$1.81M28.6%History
ATRAAtara Biotherapeutics, Inc.COM50,000$778.0K12.3%History
ZNTLZentalis Pharmaceuticals, Inc.COM10,000$532.0K8.4%History
TCRRTCR2 Therapeutics Inc.COM30,000$492.0K7.8%History
ACCDAccolade, Inc.COM7,000$380.0K6.0%History
JAZZJazz Pharmaceuticals plcSHS USD2,000$355.0K5.6%History
GRTSGritstone bio, Inc.COM35,000$320.0K5.0%History
SKINSkinHealth Systems Inc.COM CL A10,000$168.0K2.6%History